Anesthesia and Developing Brains — Implications of the FDA Warning
Top Cited Papers
- 9 March 2017
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 376 (10), 905-907
- https://doi.org/10.1056/nejmp1700196
Abstract
For more than 15 years, the potential for lasting neurotoxic effects of agents used to induce general anesthesia and sedation when administered to young children — and indirectly through pregnant women to fetuses with developing brains — has been a subject of concern and considerable research interest. The topic has been the focus of three public hearings by the Food and Drug Administration (FDA) since 2007, including an FDA Science Board meeting in November 2014, to better inform the public and practitioners about this potential problem and to foster a discussion between parents and physicians about potential risks posed by using anesthesia in young children.Keywords
This publication has 5 references indexed in Scilit:
- Summary of the Update Session on Clinical Neurotoxicity StudiesJournal of Neurosurgical Anesthesiology, 2016
- Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later ChildhoodJAMA, 2016
- Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trialThe Lancet, 2015
- Impact of anaesthetics and surgery on neurodevelopment: an updateBritish Journal of Anaesthesia, 2013
- Early Exposure to Anesthesia and Learning Disabilities in a Population-based Birth CohortAnesthesiology, 2009